Physician Assistant Exam Review

  • About
  • Contact
  • Blueprint
  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails
You are here: Home / Podcasts / S2 E035 Diabetes Type 1

S2 E035 Diabetes Type 1

http://traffic.libsyn.com/physicianassistantexamreview/035_DM_type_1.mp3

Podcast: Play in new window | Download


<< Click here to get 25 Endocrinology questions straight from my book, The Final Step >>

Kit for measuring the blood glucose level and insulinDiabetes

  • Insulin
    • Produced in the pancreas by specialized cells called islet cells. They make up 1–2% of the mass of the pancreas but yes 10–15%of the blood supply to it. Islet means small island
    • Increases cellular uptake of glucose
    • A MAJOR anabolic hormone

DM Type 1

  • When the pancreas produces little or no insulin
    • 5–10% of diabetes is type 1
    • Greater than 95% diabetes type 1 is secondary to autoimmune disease affecting the islet beta cells of the pancreas.
    • Average age of diagnosis is 14 (previously known as juvenile diabetes)
    • Normal or low body weight
    • DM is the leading cause of blindness in the United States
    • DM accounts for approximately 30% of end stage renal disease in the U.S.
    • DM patients are at increased risk for atherosclerosis

Clinical Findings

  • Early Disease Symptoms
    • DM may present with mild signs of hypoglycemia
      • Urinary frequency, polyuria, and polydipsia
      • Orthostatic hypotension and dehydration.
      • Weakness
      • Fatigue
      • Nausea and vomiting
      • Weight loss
      • Blurred vision
      • Poor wound healing
      • Bacterial and fungal infections
    • Patients may present in ketoacidosis
      • Very ill appearance
      • Nausea/vomiting
      • Polyuria & polydipsia secondary to hyperosmolar state
      • Abdominal pain
      • Change in mental state all the way two stupor
      • Fruity breath
  • Late Disease Symptoms
    • Eyes
      • Diabetic Retinopathy
        • After 20 year so DM 80% of patients will have retinopathy
        • Leaky weakened blood vessels. New weak blood vessels form and create scaring.
        • Symptoms
          • Increasing number of floaters
          • Blurry vision,
          • Vision that changes sometimes from blurry to clear,
          • Blank or dark areas in your field of vision,
          • Poor night vision
          • Colors appear faded or washed out
        • Fundal exam
          • Cotton-wool spots
          • Flame hemorrhages, dot/blot hemorrhage
    • Orthostatic hypotension due to to autonomic neuropathy and low plasma volume
    • Acanthosis nigricans
    • Neuropathy
      • Loss of sensation in limbs in a stocking glove distribution.
      • 50–80% of non traumatic lower extremity amputations are secondary to DM.
    • Atonic bladder
    • Erectile dysfunction
    • Delayed gastric emptying

Labs

  • Fasting blood glucose levels of >126 mg/dL on more than one occasion is diagnostic
  • Nonfasting blood glucose of >200 mg/dL
  • If above tests are negative but symptoms persist an oral glucose tolerance can be diagnostic. Fasting patient consumes 75 g oral glucose. Two hours later glucose level > 200 mg/dL is diagnostic
  • Hemoglobin A1c – indicates sugar levels over previous 3 months and is used for monitoring glucose control. 3.8–5.7% is normal. 5.7–6.3% is considered at risk. Over 6.3% is diagnostic.
  • Patients may have glucosuria and ketonuria

Treatment

  • All type 1 diabetics require insulin replacement therapy
  • Insulin is administered subcutaneously
  • Insulin is categorized by the rate it is metabolized
    • Rapid acting insulin
      • Lispro (Humalog), aspart (Novolog)
      • Onset: 5–15 minutes
      • Peak: 1–1.5 hours
      • Effective duration: 3–4 hours
    • Short acting insulin
      • Regular (Human R), (Novolin R)
      • Onset: 30–60 minutes
      • Peak: 2 hours
      • Effective duration: 6–8 hours
      • Used before meals
    • Intermediate acting insulin
      • NPH (Neutral protamine hagedorn), insulin zinc (Lente)
      • Onset: 2–4 hours
      • Peak: Flat
      • Effective duration: about 24 hours
      • Typically two doses daily and used in conjunction with a short acting insulin – Long acting insulin
      • Extended insulin zinc (Ultralente), Insulin glargine (Lantus)
      • Onset: 30–180 minutes
      • Peak: Lantus no peak, Ultralente 10–20hrs
      • Effective duration: 20–36 hrs
  • Diet & Education
    • Management of diet is extremely important
    • Increase fiber and complex carbohydrates – Monitor carbohydrate intake
    • Patient glucose monitor
  • Patients have increased risk for cardiovascular events
    • Treat HTN aggressively
    • Manage hyperlipidemia
  • Regular visits to podiatrist for foot care secondary to neuropathy
  • Regular diabetic eye exams

 


<< Click here to get 25 Endocrinology questions straight from my book, The Final Step >>

  • Blueprint
  • Products
  • About
  • Contact
  • Daily Emails

logo Privacy Policy | Fulfillment Policy | Terms of Service | Web design by OptimWise

 

Loading Comments...